Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

Several juxtaposed images of different patients with different responses to the cancer treatment

Study with mint Lesion™ compares the Efficacy of SIRT and CS-PHP in Uveal Melanoma with Hepatic Metastasis

A study conducted by researchers at University Hospital Tuebingen retrospectively compared two liver-targeted therapies for uveal melanoma patients with liver metastases. The results showed that Chemosaturation-Percutaneous Hepatic Perfusion (CS-PHP) had significantly longer overall survival (516 days) compared to Transarterial Radioembolization (SIRT) (300.5 days).

mint Lesion™ was used to assess the treatment efficacy in line with the Response Evaluation Criteria in Solid Tumors (RECIST 1.1). The study observed that the disease control rate, which includes Complete Response (CR), Partial Response (PR), and Stable Disease (SD), was 18% for SIRT and 30% for CS-PHP.

These findings highlight the need for further research and prospective randomized trials to optimize liver-targeted treatment strategies and address the challenges faced by patients with this condition. Learn more.

Clinical Trials Clinical Routine Standardized Reading Procedures Therapy Response Assessment Data Collection RECIST Research with mint

Related Resources

Related Resources

Picture of Dr. Maurice Heimer, radiology resident

Insights into the BORN Project: Development and Successes with Dr. Maurice Heimer

The BORN-project of the Bavarian Center for Cancer Research (BZKF) is making swift progress in its second funding phase. A key aspect of the project…

A Closer Look at the BZKF BORN-Project: Interview with Dr. Maurice Heimer from the Clinic and Polyclinic for Radiology at the LMU Klinikum

The Bavaria-wide Oncological Radiology Network (BORN) is now in its second funding phase and is making rapid progress. The project was initiated in…

Illustrations of solid pseudopapillary neoplasms and pancreatic neuroendocrine neoplasms

Heidelberg University Hospital: Key Imaging Features to Distinguish Solid Pseudopapillary Neoplasms from Pancreatic Neuroendocrine Neoplasms

Solid pseudopapillary neoplasms (SPNs), or Frantz tumors, are rare pancreatic tumors accounting for 2-3% of all pancreatic neoplasms. These tumors…